谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study

Roberto Iacovelli,Chiara Ciccarese,Sebastiano Buti,Paolo Andrea Zucali,Emanuela Fantinel,Davide Bimbatti,Elena Verzoni,Caterina Accettura,Lucia Bonomi,Consuelo Buttigliero,Giuseppe Fornarini, Stefania Pipitone,Francesco Atzori,Cristina Masini,Francesco Massari,Francesca Primi,Alessandro Strusi,Giulia Claire Giudice,Matteo Perrino,Marco Maruzzo

European Urology（2024）

引用 0|浏览48
暂无评分
关键词
Avelumab,Axitinib,Interruption,Immunotherapy,Renal cell carcinoma,Vascular endothelial growth factor receptor tyrosine kinase inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要